← Return to Webinar: What Women Need to Know about Ovarian Cancer

Event
Webinar: What Women Need to Know about Ovarian Cancer Event Date: May 12, 2015 | 12:00pm - 1:00pm ET
Comment receiving replies
@gwenbasinger

By initial surgery for qualification for the Avatar study, do you mean surgery at initial diagnosis? I had platinum based treatment in first occurrence, 10 months NED, recurrence and now not responding to second line treatment. Am I a candidate for the Avatar study?

Jump to this post

Replies to "By initial surgery for qualification for the Avatar study, do you mean surgery at initial diagnosis?..."
Alex White | @aiwhite | May 19, 2015

The upcoming Avatar study will be open for women who are having their initial debulking surgery. Since you have already started second line therapy, we wouldn’t be able to make an Avatar for you in time to help. This process takes several months. However, there is a clinical trial open at Mayo (MC1464; clinicaltrials.gov identifier: NCT02283658) for women with recurrent ovarian cancer. This is a phase II study in which women with hormone receptor positive ovarian cancer are treated with everolimus and letrozole. As part of the study, an Avatar is made. The Avatar in this study is not used to predict response to other chemotherapies; it is used to better understand the response of the woman’s cancer to the study drugs—everolimus and letrozole. More details on this study can be found at: https://clinicaltrials.gov/ct2/show/NCT02283658?term=MC1464&rank=1

VIEW AND REPLY